Neuronetics Inc. (STIM)
Pitch Summary: Neuronetics (STIM) is positioned as the emerging platform leader in non-drug, non-invasive mental health treatment through its NeuroStar TMS system and recent Greenbrook TMS acquisition. The combined entity now controls the largest integrated TMS and esketamine therapy network in the U.S. (~400+ clinics). TMS is FDA-cleared, clinically validated, and gaining reimbursement traction, particularly […]
Harrow, Inc. (HROW)
Pitch Summary: Harrow is an ophthalmology-focused pharma platform that has leveraged its ImprimisRx compounding footprint (10k+ prescribers) to in-license and scale branded eye-care drugs with low up-front cost and pay-as-you-go royalties. The crown jewels are VEVYE (cyclosporine 0.1% in Novaliq’s SFA vehicle) and IHEEZO (topical ocular anesthetic), both showing rapid adoption with improving access and […]
Safety Insurance Group, Inc. (SAFT)
Pitch Summary: Safety Insurance is a New England–focused personal lines P&C carrier (MA/NH/ME) that the author argues is mispriced at ~125% of tangible book value with a 5% dividend and no net debt. Earnings power looks depressed after two tough weather/claims-inflation years (2023–24 combined ratios 108%/101%), but written-rate momentum is strong: 2024 average written premium […]
Tetra Tech, Inc. (TTEK)
Pitch Summary: Tetra Tech is a global engineering and consulting firm focused on water, environmental services, and sustainable infrastructure, with a diversified mix across U.S. federal, state & local, commercial, and international clients. The stock fell ~40% on fears tied to U.S. aid/federal cuts, but management has already removed virtually all USAID exposure from guidance […]
FinVolution Group (FINV)
Pitch Summary: FinVolution is a China-based, asset-light consumer credit facilitator that matches online borrowers with >100 institutional partners and monetizes via facilitation/servicing fees. Since pivoting away from P2P in 2021, it has delivered uninterrupted YoY growth despite COVID and regulatory resets, with H1’25 revenue +11.5% and operating income +43%. Roughly 80% of revenue remains China, […]
23andMe Holding Co. (MEHCQ)
Pitch Summary: This pitch frames 23andMe as an unusual post-bankruptcy liquidation play with clear downside protection and asymmetric upside optionality. Once a notorious cash-burning genomics and health data company led by Anne Wojcicki, 23andMe filed for Chapter 11 in March 2025 after a failed take-private bid and a governance breakdown. A July 2025 asset sale—including […]
Farmers & Merchants Bank of Long Beach (FMBL)
Pitch Summary: The pitch highlights an event-driven opportunity in Farmers & Merchants Bank of Long Beach (FMBL), a thinly traded, family-controlled community bank trading OTC with a ~$6,450 share price and ~$800M market cap. The author notes multiple signals suggesting imminent corporate action: proposed bylaw amendments lowering supermajority thresholds for mergers/sales from 80% to 65%, […]
Sanlorenzo S.p.A. (SL.MI)
Pitch Summary: The pitch presents Sanlorenzo as a “quiet luxury” Italian superyacht maker with a durable made-to-measure model, disciplined scarcity, and exceptional returns on tangible capital (~50%). Led by long-time owner-operator Massimo Perotti, the firm has scaled from an artisanal base to a top global player while preserving customization as its moat. The portfolio spans […]
Amer Sports, Inc. (AS)
Pitch Summary: The pitch argues Amer Sports is a China-backed multi-brand premium sports platform (Arc’teryx, Salomon, Wilson) that can sustain above-consensus growth and margins via aggressive DTC expansion, brand “premiumization,” and rapid China/APAC store rollouts. Since the 2019 take-private by Anta/Tencent/Chip Wilson, revenue has doubled to ~$5–6B with DTC mix rising from ~22% to ~46%, […]
Frontier Group Holdings, Inc. (ULCC)
Pitch Summary: The pitch argues Frontier’s post-COVID economics are structurally broken: while branded as an ultra-low-cost carrier, its de facto profit engine since 2021 has been sale-leasebacks (SLBs) on a large A320neo/A321neo order book, not flying. Despite SLB gains that inflated GAAP margins, core airline operations have produced persistent negative free cash flow as maintenance, […]
Steep Hill Inc. (STPH)
Pitch Summary: Steep Hill (STPH) is a microcap on the CSE that has effectively become a cash-backed public shell after exiting its cannabis testing/IP operations. As of June 30, 2025, it reported ~C$1.95mm of working capital versus a ~C$0.81mm market cap, allowing investors to buy ~C$0.12/share of net current assets for ~C$0.05/share. The company’s balance […]
Swedencare AB (publ) (SECARE)
Pitch Summary: Swedencare (SECARE) is a premium pet-supplements platform leveraged to long-duration “pet humanization” tailwinds across North America and Europe, with emerging ROW optionality. The category is still nascent (~$2B in the U.S.) yet growing faster than human supplements, providing a long runway as penetration rises from a low base. SECARE is the scaled #2 […]
GEO Group Inc. (GEO)
Pitch Summary: GEO Group (GEO) is at a key inflection point as investors misread both the near-term catalysts and the broader demand drivers for detention and electronic monitoring capacity. The stock has been punished following delays in contract signings and deferred growth in its monitoring division, but high-frequency ICE data now shows daily book-ins exceeding […]
Immuneering Corp. (IMRX)
Pitch Summary: Immuneering is a $250M-market-cap oncology biotech that could rerate sharply on imminent pancreatic cancer data. Its lead asset IMM-1-104, a dual MEK inhibitor employing “deep cyclic inhibition,” has shown extraordinary early survival data in Phase 2 for 1L pancreatic adenocarcinoma, a ~$10B global market (50k U.S. patients). After a March 2024 disappointment drove […]
Dole PLC (DOLE)
Pitch Summary: Dole is a global leader in fresh fruit & veg created by the 2021 merger of Total Produce and legacy Dole. Shares screen as an orphaned value: ~0.3x EV/Sales, ~9.7x ’25 EPS, ~5.8x adj. EBITDA (midpoint guide), ~12–17% levered FCF yield on recent years. Near-term set-ups: (1) large 2H working-capital release (historically strong […]
Smithfield Foods Inc. (SFD)
Pitch Summary: Smithfield Foods (SFD) has evolved from a cyclical, low-margin pork processor into a stable, branded consumer packaged goods (CPG) company. Following its 2013 buyout and 2024 IPO, Smithfield has streamlined operations, focusing on high-margin packaged meats (75% of profits) while shrinking its volatile hog production business (targeting ~70% outsourced). Its packaged products — […]
International Paper Co. (IP)
Pitch Summary: A short predicated on “rock star CEO” hype outrunning commodity reality. New CEO Andy Silvernail (ex-IDEX/Danaher playbook) has guided to aggressive 2027 targets (EBITDA ex-pulp $5.5–6.0B; big FCF ramp) while promising “above-market” volume growth and price increases. The author argues these clash with 30 years of flat U.S. corrugated box demand, IP’s role […]
PopMart (S) (9992.HK)
Pitch Summary: PopMart (9992.HK) is priced like a durable global IP platform at ~11–12x 2025E sales and a ~$49–50bn market cap, but its fundamentals resemble a late-stage consumer fad. Growth remains heavily concentrated in the Labubu franchise, which accounts for roughly 35% of 1H25 sales, leaving the company highly exposed to single-IP fatigue. High-frequency data […]
ALT5 Sigma Corp. (ALTS)
Pitch Summary: ALT5 Sigma is a hyper-speculative play on Trump-linked crypto token World Liberty Financial (WLFI). The company acquired ~$1.5B of WLFI governance tokens at $0.20 and trades at a steep discount to its reported NAV (~$6.40/share vs. ~$4 market price). While fundamentally fragile—its core value tied to volatile WLFI—ALTS could surge from a meme-driven […]
Tourmaline Oil Corp. (TOU)
Pitch Summary: Canada’s largest nat-gas producer positioned as the “last man standing” as U.S. Tier-1 shale inventory depletes and LNG + AI/data-center power loads drive a structural North American gas deficit. Thesis: Montney/Deep Basin depth (≈75-yr drilling runway), lowest cost (~$1.50/mcf maint. breakeven), investment-grade balance sheet (~0.5× ND/’25 EBITDA), midstream integration, and global price exposure […]
